Notably, pretreated neuroblastoma cell lines with sesamin and sesamol are potentially protected from oxidative stress through the activation of the SIRT1-SIRT3-FOXO3a pathway, which could be effective in HD treatment (Kumar et al., 2010; Ruankham et al., 2019). This evidence concerns the gene SIRT3 and Huntington disease.